In this sense, IGF-1 activates PI3K/Akt [77], and induces EMT of HCC via the Stat5 signaling pathway [78], and is also involved in the regulation of the p53 signaling pathway [75]. Here, IGF1 is linked to hepatocellular carcinoma.